Drug Safety

Associate Professor David W.J. Clark: 1940-2011
pp. 615-616(2)
Authors: Coulter, David; Harrison-Woolrych, Mira

Conflicts of Interest in Medicines Safety and Regulation: How Much Conflict and How Much Interest Should We Allow?
pp. 617-621(5)
Author: Edwards, I. Ralph

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review
pp. 623-639(17)
Authors: Watkins, Crystal C.; Pieper, Andrew A.; Treisman, Glenn J.

Drug Treatment for Obesity in the Post-Sibutramine Era
pp. 641-650(10)
Author: Cheung, Bernard M.Y.

Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
pp. 651-668(18)
Authors: Pringsheim, Tamara; Lam, Darren; Ching, Heidi; Patten, Scott

Rates of Spontaneous Reports of Adverse Drug Reactions for Drugs Reported in Children: A Cross-Sectional Study with Data from the Swedish Adverse Drug Reaction Database and the Swedish Prescribed Drug Register
pp. 669-682(14)
Authors: Wallerstedt, Susanna M.; Brunlöf, Gertrud; Sundström, Anders

Clarity and Applicability of Drug-Drug Interaction Management Guidelines: A Systematic Appraisal by General Practitioners and Community Pharmacists in the Netherlands
pp. 683-690(8)
Authors: Floor-Schreudering, Annemieke; De Smet, Peter A.G.M.; Buurma, Henk; Amini, Sonia; Bouvy, Marcel L.

Delivery Outcome after Maternal Use of Drugs for Migraine: A Register Study in Sweden
pp. 691-703(13)
Authors: Källén, Bengt; Nilsson, Emma; >Petra Otterblad Olausson,

The Fatal Love of Forms
pp. 705-707(3)
Author: Hugman, Bruce